logo
Plus   Neg
Share
Email

Medtronic: FDA Approves Pipeline Flex Embolization Device With Shield Technology

Medtronic plc (MDT) has received FDA approval for Pipeline Flex Embolization Device with Shield Technology. NYU Langone Health in New York City performed the first patient procedure with the device.

Medtronic developed Shield Technology to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots.

"In addition to addressing material thrombogenicity, Shield Technology improves device performance by reducing the force required for both delivery and resheathing of the device," said Dan Volz, president of the Neurovascular business, which is part of the Neuroscience Portfolio at Medtronic.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart has dropped the requirement of masks for customers and members who are fully vaccinated against COVID-19 while they are at the store. This is based on the latest guidance issued by the Centers for Disease Control and Prevention late last week. The retail giant also announced a cash bonus for all fully vaccinated associates. Amazon announced the launch of WorkingWell, a new comprehensive program providing employees with physical and mental activities, wellness exercises, and healthy eating support, across its U.S. Operations. The program has a number of components covering training and conditioning, wellness services, and technology. Each of WorkingWell's components were developed in collaboration with employees. The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert for around 165 pounds of imported frozen Siluriformes products. The products were imported from Brazil, which is ineligible to export Siluriformes products to the United States.
Follow RTT